miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
Zou, Zhenyou, Zou, Ruyi, Zong, Dan, Shi, Yonghong, Chen, Jinyao, Huang, Jie, Zhu, Jiahui, Chen, Liguan, Bao, Xiaoyan, Liu, Yuan, Liu, Weihao, Huang, Wenhui, Hu, Jingsang, Chen, Zhi, Lao, Xiaojie, Chen, Chaoqun, Huang, Xiaoli, Lu, Yao, Ni, Xueyin, Fang, Daoquan, Wu, Dengqiang, Lu, Shuangshuang, Jiang, Mingzhu, Qiu, Chenyang, Wu, Yuya, Qiu, Qisha, Dong, Yanyuan, Su, Yangyang, Zhao, Chenmin, Zhong, Zhihe, Cai, Jing, Liang, Yong
Published in Journal of cellular and molecular medicine (01.09.2017)
Published in Journal of cellular and molecular medicine (01.09.2017)
Get full text
Journal Article